Sernova Biotherapeutics Inc (ETR:PSH0)
Germany · Delayed Price · Currency is EUR 0.0910
0.00 (0.00%)
At close: Feb 13, 2026
Sernova Biotherapeutics Company Description
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada.
The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions.
Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability.
Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025.
Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Sernova Biotherapeutics Inc
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Jonathan M. Rigby |
Contact Details
Address: RPO Central Parkway Mississauga, ON L5A 4H2 Canada | |
| Phone | 917-751-5713 |
| Website | sernova.com |
Stock Details
| Ticker Symbol | PSH0 |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | November - October |
| Reporting Currency | CAD |
| ISIN Number | CA81752F1062 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jonathan M. N. Rigby M.B.A. | Chief Executive Officer and Director |
| James T. Parsons CPA-CA, MAcc | Chief Financial Officer |
| David Burke | Vice President of Investor Relations |
| Marylyn Rigby | Chief Communications Officer |
| Dr. Pericles Calias Ph.D. | Chief Development Officer and Head of Research & Development |